Search hospitals > Iowa > Des Moines

Mission Cancer and Blood - Laurel

Claim this profile
Des Moines, Iowa 50314
Global Leader in Breast Cancer
Global Leader in Esophageal Cancer
Conducts research for Relapse
Conducts research for Breast cancer
Conducts research for Lung Cancer
172 reported clinical trials
1 medical researcher
Photo of Mission Cancer and Blood - Laurel in Des MoinesPhoto of Mission Cancer and Blood - Laurel in Des MoinesPhoto of Mission Cancer and Blood - Laurel in Des Moines

Summary

Mission Cancer and Blood - Laurel is a medical facility located in Des Moines, Iowa. This center is recognized for care of Breast Cancer, Esophageal Cancer, Relapse, Breast cancer, Lung Cancer and other specialties. Mission Cancer and Blood - Laurel is involved with conducting 172 clinical trials across 339 conditions. There are 1 research doctors associated with this hospital, such as Richard L. Deming.

Area of expertise

1Breast Cancer
Global Leader
Mission Cancer and Blood - Laurel has run 92 trials for Breast Cancer. Some of their research focus areas include:
Stage IV
Stage III
Stage II
2Esophageal Cancer
Global Leader
Mission Cancer and Blood - Laurel has run 29 trials for Esophageal Cancer. Some of their research focus areas include:
Stage IV
Stage III
BRCA1 positive

Top PIs

Clinical Trials running at Mission Cancer and Blood - Laurel

Breast Cancer
Lung Cancer
Bladder Cancer
Breast cancer
Non-Small Cell Lung Cancer
Multiple Myeloma
Kidney Cancer
Cancer
Skin Cancer
Melanoma
Image of trial facility.

Crizotinib

for Non-Small Cell Lung Cancer

This randomized phase III trial studies how well crizotinib works in treating patients with stage IB-IIIA non-small cell lung cancer that has been removed by surgery and has a mutation in a protein called anaplastic lymphoma kinase (ALK). Mutations, or changes, in ALK can make it very active and important for tumor cell growth and progression. Crizotinib may stop the growth of tumor cells by blocking the ALK protein from working. Crizotinib may be an effective treatment for patients with non-small cell lung cancer and an ALK fusion mutation.
Recruiting2 awards Phase 328 criteria
Image of trial facility.

Chemotherapy + Hormone Therapy

for Breast Cancer

This trial is testing if adding additional cancer-fighting drugs to treatments that stop certain body functions is better than just using the treatments that stop those functions alone. It targets younger women with early-stage breast cancer who have a higher risk of dying from the disease. The treatment works by stopping certain body functions and using drugs to kill cancer cells.
Recruiting2 awards Phase 319 criteria
Image of trial facility.

Focused Radiation vs Systemic Therapy

for Kidney Cancer

This phase III trial compares the effect of stero-ablative radiotherapy (SAbR) followed by standard of care systemic therapy, to standard of care systemic therapy alone, in patients with kidney cancer that has spread from where it first started (primary site) to a limited (2-5) number of places in the body (metastatic). Study doctors want to find out if this approach is better or worse than the usual approach for metastatic kidney cancer. The usual approach is defined as the care most people get for metastatic kidney cancer which includes systemic therapy such as immunotherapy (given through the veins) and/or small molecular inhibitor (tablets taken by mouth). Radiotherapy uses high energy x-rays to kill cancer cells and shrink tumors. SAbR uses special equipment to position a patient and deliver radiation to tumors with high precision. Giving SAbR prior to systemic therapy may kill more tumor cells than the usual approach, which is systemic therapy alone.
Recruiting2 awards Phase 319 criteria

Similar Hospitals nearby

Frequently asked questions

What kind of research happens at Mission Cancer and Blood - Laurel?
Mission Cancer and Blood - Laurel is a medical facility located in Des Moines, Iowa. This center is recognized for care of Breast Cancer, Esophageal Cancer, Relapse, Breast cancer, Lung Cancer and other specialties. Mission Cancer and Blood - Laurel is involved with conducting 172 clinical trials across 339 conditions. There are 1 research doctors associated with this hospital, such as Richard L. Deming.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top
Terms of Service·Privacy Policy·Cookies·Security
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top
Terms of Service·Privacy Policy·Cookies·Security